23 C
New York
Saturday, June 6, 2026

Tag: distribution agreement

newssourceFORcompanyinformationcontent1marketreleases

Allianz Partners to Acquire nib Travel Portfolio, Strengthening Australian Market Offering

BRISBANE, Australia, June 5, 2026 /PRNewswire/ -- Allianz Partners today announced it has signed an agreement to acquire a large portion of nib's Australian...

Pediatric Relapsed/Refractory Neuroblastoma Market is on an Upward Trend, Driven by Innovation and Unmet Need | DelveInsight

The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...

Pediatric Relapsed/Refractory Neuroblastoma Market is on an Upward Trend, Driven by Innovation and Unmet Need | DelveInsight

The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...

Infrastructure Dividend Split Corp. Establishes At-the-Market Equity Program

Not for distribution to U.S. Newswire Services or for dissemination in the United States.

Univar Solutions and BASF Expand Distribution Agreement to Deliver Key Ingredients for High-Performance Polyurethane, Coatings, Adhesives, and Polymer Systems in Industrial Manufacturing

New agreement will help meet the growing demand for high-performance formulations in polyurethane, coatings, and adhesives production in the United States and Canada DOWNERS GROVE,...

Univar Solutions and BASF Expand Distribution Agreement to Deliver Key Ingredients for High-Performance Polyurethane, Coatings, Adhesives, and Polymer Systems in Industrial Manufacturing

New agreement will help meet the growing demand for high-performance formulations in polyurethane, coatings, and adhesives production in the United States and Canada DOWNERS GROVE,...

Alpha Global partners with LIO to redefine Mental Health Care in Australia

New platform boosts patient experience and safety, reduces clinician burden, and unlocks operational insight across inpatient mental health hospitals SYDNEY, Aug. 13, 2025 /PRNewswire/ --...

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDistribution agreement

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers